Please login to the form below

Not currently logged in

Novartis tops leaderboard at PM Society Digital Media Awards

Secures four wins for two separate campaigns

Novartis Ruder Finn meningitis campaign 

Novartis Vaccines and Diagnostics picked up the largest haul at last week's PM Society Digital Media Awards in London.  

The company's four wins from two campaigns saw it just edge out AstraZeneca, which picked up three prizes, at the annual marketing event.  

Novartis' winning work was led by the Ruder Finn produced Meningitis: Keep Watching campaign (pictured above).  

This picked up awards for best integrated multi-channel campaign and digital patient communications programme - patient education, as well as the social media prize.  

Meanwhile, the pharma company's in-pharmacy vaccination programme by Radical Departures picked up the joint working/NHS partnerships award.  

Close behind Ruder Finn was Digitas Health, which picked up two awards, taking home the craft award – mobile for its Symbicort Mobile App on behalf of AstraZeneca.  

The agency also scored in the craft award – gamification with its JAK Pathways Augmented Reality Challenge for Pfizer.  

The Digital Awards' individual categories were led by GlaxoSmithKline's global digital director Kai Gait, who walked away with the digital pioneer award.  

Meanwhile, the digital project/account management award was picked up by Aurora Healthcare Communication's senior account manager Gill Dunn, while Kristen Grant of Waggener Edstrom was recognised with a high commendation.  

Now in its fifth year, the Digital Media Awards judges reported more consistently high standards across all categories and increased integration of digital into marketing strategies.

30th September 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...